Stifel Financial Corp Xenon Pharmaceuticals Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 21,571 shares of XENE stock, worth $839,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,571

Previous 22,083 2.32%

Holding current value

$839,111

Previous $861,000 1.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $18,493 - $22,507	-512 Reduced 2.32%	21,571 $848,000
Q2 2024 Aug 13, 2024	SELL	$36.25 - $43.75 $3,335 - $4,025	-92 Reduced 0.41%	22,083 $861,000
Q1 2024 May 13, 2024	BUY	$42.66 - $50.04 $55,202 - $64,751	1,294 Added 6.2%	22,175 $954,000
Q4 2023 Feb 12, 2024	BUY	$28.7 - $46.46 $11,508 - $18,630	401 Added 1.96%	20,881 $961,000
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $13,629 - $15,852	399 Added 1.99%	20,480 $699,000
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $340,630 - $425,690	9,777 Added 94.89%	20,081 $773,000
Q1 2023 May 12, 2023	BUY	$33.46 - $40.35 $12,045 - $14,526	360 Added 3.62%	10,304 $368,000
Q4 2022 Feb 13, 2023	SELL	$33.06 - $39.43 $3,306 - $3,943	-100 Reduced 1.0%	9,944 $392,000
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $20,937 - $28,936	-823 Reduced 7.57%	10,044 $306,000
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $15,480 - $20,441	-617 Reduced 5.37%	10,867 $332,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $8,673 - $19,682	556 Added 5.09%	11,484 $358,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $162,390 - $212,549	10,928 New	10,928 $167,000
Q3 2018 Nov 13, 2018	SELL	$9.0 - $14.9 $103,500 - $171,350	-11,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$4.8 - $9.2 $1,800 - $3,449	-375 Reduced 3.16%	11,500 $106,000
Q1 2018 May 11, 2018	SELL	$2.7 - $4.9 $27,877 - $50,592	-10,325 Reduced 46.51%	11,875 $58,000
Q4 2017 Feb 14, 2018	BUY	$2.2 - $3.25 $1,100 - $1,625	500 Added 2.3%	22,200 $63,000
Q3 2017 Nov 13, 2017	BUY	$2.45 - $3.25 $53,165 - $70,525	21,700	21,700 $0

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Xenon Pharmaceuticals Inc. Transaction History